Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Air purifier that kills H5N1 bird flu launched by Tri-Air Developments
February 14th, 2007
British scientists have developed an air purifier that kills colds and flu germs, including H5N1 bird flu, as well as MRSA and anthrax. Unlike air filtration devices, the system simulates the production of fresh air to destroy airborne viruses and bacteria in minutes within private, work and public spaces. With worldwide patents pending, the biotechnology unit uniquely combines three established decontamination technologies to overcome their inherent individual shortcomings: non-thermal plasma; ultraviolet catalysis; and 'open air factor'. This creates a fresh air environment that is lethal to viruses, including H5N1 - which, if a pandemic occurs, is...
Source: Medical Patent Law Weekly (2007-02-14)
|
